Real-time enrollment status for this borderline resectable pancreatic ductal adenocarcinoma clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 3:58 PM UTC
| NCT Number | NCT07705919 |
| Recruiting Status | Recruiting |
| Condition | Borderline Resectable Pancreatic Ductal Adenocarcinoma |
| Phase | PHASE1 |
| Target Enrollment | 50 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Ohio State University Comprehensive Cancer Center |
| Last Updated on CT.gov | October 5, 2026 (1 week ago) |
As of October 12, 2026: Clinical trial NCT07705919 is currently recruiting participants. This phase1 study for borderline resectable pancreatic ductal adenocarcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Ohio State University Comprehensive Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07705919 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07705919 was last updated 1 week ago (October 5, 2026). HelloStudys verifies this status automatically.